Se Habla Español
359-8580 Salt Lake
800.367.6955 Otro Sitio
LNMH AV rated
Call Toll Free: 1-888-393-2029
Robert DeBry

Salt Lake City
4252 South 700 East
Salt Lake City, Utah 84107
Phone: 866.610.4529
Toll Free: 800.232.8915
Español: 800.367.6955

St. George
243 East St. George Blvd.
Suite 110
St George, Utah 84770
Phone: 435.656.0198
Toll Free: 800.909.3500
Español: 877.879.1989

We can usually tell you if you have a good case


Robert DeBry and Associates
Robert DeBry and Associates Click Here For A Free Consultation

KIDNEY FAILURE (FDA ALERT FOR TRASYLOL)

SPECIAL ALERT
for people who suffer from
KIDNEY FAILURE
(Sometimes called renal failure)
If you or a loved one has
developed kidney failure AFTER
heart surgery or AFTER coronary
bypass surgery, you may be
entitled to a large
financial settlement.

For complete details:
CALL - Robert DeBry & Associates
262-8915 Local
or Toll Free
1-866-Try DeBry

Trasylol®: What You Should Know
Trasylol® is commonly administered in patients undergoing coronary artery bypass graft surgery (CABG). The procedure is used to alleviate plaque deposits that significantly inhibit the flow of blood to the heart muscle. While the CABG procedure is relatively safe, some patients may experience complications that can lead to serious injury and even death.

The mass tort team at DeBry & Associates, is carefully monitoring the progression of the FDA Trasylol® Advisory that was issued after two recent research studies identified potential risks.

What Led to the Trasylol® Advisory?
The studies identified a correlation between the use of Trasylol® and an increased risk of kidney problems, heart attacks and strokes in people who have been given the drug during coronary artery bypass graft surgery (CABG).
The FDA also advised that doctors should carefully weigh the potential benefits and risks of Trasylol® before administering the drug to their patients. Furthermore, any patients who are given the drug should be carefully monitored for signs of toxicity to the kidneys, heart and central nervous system. Any adverse events must be promptly reported to Bayer or the FDA Medwatch program.

Who Should I Contact?
Patients who have experienced complications after coronary artery bypass surgery should contact their medical providers to determine if Trasylol® was used for their procedure. If Trasylol® was administered, the drug may have factored into post-surgical complications.
If you feel you may have been adversely affected by the use of Trasylol® and have experienced any of the following problems after coronary artery bypass graft surgery. . .

Potential Risks of Trasylol® Use

  1. Kidney Problems
  2. Heart Attack
  3. Stroke

Other Resource:
www.fda.gov/bbs/topics/news/2006/NEW01311.html

If you or a loved one has experienced kidney failure AFTER coronary bypass surgery, call or email us to learn about your rights. . .you may be entitled to compensation.

CALL US NOW for a free consultation.

CALL TOLL FREE: 1-888-393-2029
Email Us

HOT TOPICS

YAMAHA RHINO ROLLOVERS(Serious injuries & death)

Postarthroscopic Glenohumeral Chondrolysis (Pain Pump)

DIGITEK RECALL

HEPARIN CONTAMINATION

KIDNEY FAILURE (FDA ALERT FOR TRASYLOL)

Medtronic Sprint Fidelis® Heart Defibrillator Leads Voluntary Recall

AVANDIA SAFETY ALERT

VIOXX RECALL

BEXTRA RECALL

FENTANYL MEDICAL ALERT

ORTHO EVRA MEDICAL ALERT

FOSAMAX MEDICAL ALERT

DILANTIN MEDICAL ALERT

 
  This web site is designed for general information only. The information presented at this site should not be construed to be formal legal advice nor the formation of a lawyer/client relationship. [ Site Map ]